ASN95 -- Selected abstracts: Glomerulonephritis

Sun. Nov. 5 1995

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Determination of progression

Program number 85 Board# S85 at 10:45 A.M.
* Lipid abnormalities contribute to accelerated progression of human chronic glomerulonephritis. O.Samuelsson, P-o. Attman, C. Knight-gibson, R. Larsson, H. Mulec, L. Weiss and P. Aluapovic. - Goteborg, Sweden and Oklahoma City, OK.

Program number 108 Board# S108 at 10:45 A.M.
* Urinary transforming growth factor beta 1 and progression of glomerular diseases. E. Honkanen, A-M. Teppo, T. Tornroth and C. Gronhagen-Riska. - Helsinki, Finland.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Lupus nephritis

Program number 137 Board# S137 at 10:45 A.M.
* Inducible NOS in human glomerulonephritis; the source is infiltrating monocytes/macrophages. A. Kashem, M. Endoh, F.Yamauchi, N. Yano, Y. Nomoto and H. Sakai. - Isehara, Japan.

Program number 151 Board# S151 at 10:45 A.M.
* The distribution of HBV DNA in the kidney in patients with hepatitis B virus associated glomerulonephritis. X. Zhang, A. Zhang and F. Hou. - Guangzhou, P.R. China.

Program number 152 Board# S152 at 10:45 A.M.
* Renal lesions associated with methicillin-resistant staphylococcus aureus infection. M. Kobayashi, N. Yamaguchi, K. Yoh, K. Hirayama, T. Ishizu, S. Iwabuchi, C. Tomida, K. Muro, M. Sato, S. Kikuchi, M. Igarashi, T. Iitsuka, K. Takemura, K. Yamagata and A. Koyama. - Tsukuba, Japan.

Program number 154 Board# S154 at 10:45 A.M.
* Detection of replicative hepatitis C viral RNA in kidney of patient with membrano-proliferative glomerulonephritis. T. Ando, S. Okuda and M. Fujishima. - Fukuoka, Japan.

Program number 155 Board# S155 at 10:45 A.M.
* Cryoglobulinemia in HIV-infected patients with renal disease. J. Hertel, R. Rao, T.M. Phillips and P.L. Kimmel. - Augusta, GA and Washington, DC.

Program number 156 Board# S156 at 10:45 A.M.
* Localization of hepatitis B virus (HBV) antigens and DNA in renal tissue from HBV carriers with the membranoproliferative glomerulonephritis. Y.S. Kim, S. Kim, H.J. Yoon, C. Ahn, J.S. Han, H.S. Lee and J.S. Lee. - Seoul, Korea.

Program number 158 Board# S158 at 10:45 A.M.
* Localization of HCV antigens in renal tissue of HCV-infected patients with cryoglobulinemic mesangiocapillary glomerulonephritis: An immuno-histochemical study. D. Sansonno, L. Gesualdo, C. Manno, F.P. Schena and F.Dammacco. - Bari, Italy.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Clinical transplantation: Infectious disease complications

Program number 349 Board# S349 at 10:45 A.M.
* Infection with hepatitis C virus increases the risk of de novo glomerulonephritis in renal transplant recipients. S.M. Cockfield and J.K. Prieksaitis. - Edmonton, Canada.

Program number 359 Board# S359 at 10:45 A.M.
* Pattern and prevalence of glomerulonephritis in renal transplant hepatitis C patients. S. Huraib, W. Al Khudair, S. Aburomeh, M. Quadri, A. Abdulkader, R. Said, A. Chaballout and H. Saleem. - Riyadh, Saudi arabia.

Program number 361 Board# S361 at 10:45 A.M.
* Hepatitis C virus associated membrano-proliferative glomerulonephritis in renal allograft recipients. J.M. Grinyo, J.M. Cruzado, S. Gil-Vernet, G. Ercilla, D. Seron, M. Carrera and J. Alsina. - Bercelona, spain.

Program number 382 Board# S382 at 10:45 A.M.
* Renal transplantation In membranoproliferative glomerulonephritis: A single centre study. M.B. Andresdottir, J.F.M. Wetzels, A.J. Hoitsma and R.A.P. Koene. - Nijmegen, The Netherlands.

Program number 389 Board# S389 at 10:45 A.M.
* Recurrent lupus nephritis in the renal allograft. P.N. Chander, D. Sammett, I. Argani, V. Delaney, R. Weiss, J.Tomasula and K. Butt. - Valhalla, NY.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Podocyte injury/focal segmental glomerulosclerosis

Program number 571 Board# S571 at 10:45 A.M.
* Increased albumin permeability caused by sera from patients with collapsing glomerulopathy and glomerular tip lesion. E.T. McCarthy, X. Ge, R. Sharma, M. Sharma, J.C. Jennette, R.J. Falk and V.J. Savin. - Milwaukee, WI and Chapel Hill, NC.

4:00 P.M. ---Free Communications--- San Diego Conv Ctr Rm 9
Basic immunology/pathogenesis II

Program number 680 at 4:00
* Anti-DNA antibodies structure-function and pathogenicity. K.J. Johnson, P.C. Swanson, R.L. Yung, N.B. Blatt, M.Eagan, J. Norris, B.C. Richardson and G.D. Glick. - Ann Arbor, MI.

Program number 682 at 4:30
* Treatment of anti-thy-1.1 mesangioproliferative glomerulonephritis with cyclic-3;pp, 5;pp-nucleotide phosphodiesterase isozyme antagonists, types PDE-III and PDE- IV. Y. Tsuboi, S. Shankland, J.P. Grande, H.J. Walker, R.J. Johnson and T.P. Dousa. - Rochester, MN and Seattle, WA.

4:00 P.M. ---Free Communications--- San Diego Conv Ctr Rm 2
Therapy of glomerular disease

Program number 726 at 4:00
* Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 Years follow-up of a prospective, randomized multi-center study. N. Braun, C.M. Erley, N. Benda, I. Zauner, R. Kanis, C. Grupp, M. Ackermann, P. Heering, R. Funfstuck and T. Risler. - Tubingen, Germany.

Program number 728 at 4:30
* Renal survival by race in diffuse proliferative lupus glomerulonephritis (SLE-DPGN) treated with intravenous cyclophosphamide. S.L. Hogan, M.A. Dooley, K. Lowney, J.C. Jennette and R.J. Falk. - Chapel Hill, NC.

Mon. Nov. 6 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hypertension and chronic renal failure

Program number 794 Board# M63 at 10:00 A.M.
* Are untreated normotensive blood pressure values appropriate in patients with glomerulonephritis? S. Geberth, A. Stefanski, Ch. Keller, K.G. Schmidt and E. Ritz. - Heidelberg,Germany.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
ANCA

Program number 943 Board# M212 at 10:00 A.M.
* De novo mesangial IGA nephropathy in patients with Wegener's granulomatosis and pauci-immune crescentic glomerulonephritis. K. Andrassy, R. Waldherr, M. Zeier and E. Ritz. - Heidelberg, Germany.

Program number 945 Board# M214 at 10:00 A.M.
* ANCA-associated anti-GBM glomerulonephritis: Clinical correlations and antibody specificity. F. Bridoux, J. Wieslander, D. Hestin, B. Mougenot, J. Rossert, C. Jacquot, D. Reumaux and Ph. Vanhille. - Paris, France and Lund, Sweden.

Program number 947 Board# M216 at 10:00 A.M.
* Effect of initial histology and plasmapheresis treatment on prognosis of RPGN: Results of the German prospective randomized multicenter study. J. Bohler, I. Zauner, D. Bach, N. Braun, R. Fauunfstuck, U. Helmchen and P. Schollmeyer. - Freiburg, Dusseldorf, Tubingen, Jena and Hamburg, Germany.

Program number 950 Board# M219 at 10:00 A.M.
* Outcome of children with anti-neutrophil cytoplasmic antibody positive glomerulonephritis. R.P. Valentini, A.B. Sedman, W.E. Smoyer, D. Kershaw, M. Gregory and T.E. Bunchman. - Ann Arbor, MI.

Tue. Nov. 7 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Hypertension: Clinical II

Program number 1530 Board# T80 at 10:00 A.M.
* ABP monitoring in primary glomerulonephritis patients. A. Fabbri, E. Degli Esposti, R. Cocchi, A.M. Di Nardo, A. Lucatello, M. Pretolani, A. Sturani and M. Fusaroli. - Ravenna, Italy.

9:00 A.M. ---Poster highlights--- San Diego Conv Ctr Halls A and B
Glomerular diseases

Program number 1541 at na
* Changing incidence of idiopathic glomerular diseases in adults. G. Braden, J. Mulhern, M. O'Shea, M. Germain, S. Nash and A. Ucci. - Springfield and Boston, MA.

Program number 1542 at na
* Do circulating factors contribute to proteinuria and matrix synthesis in the native kidneys of patients with idiopathic focal sclerosis? S. Feld, P. Figueroa, D. Cha, V. Savin, R. Sharma, M. Sharma, C. Nast, R. Hirschberg, J. Lapage and S.G. Adler. -Milwaukee, WI and Los Angeles, CA.

Program number 1544 at na
* Results of a 6 month randomized controlled trial of cyclosporine versus placebo in adults with steroid resistant idiopathic focal segmental glomerulosclerosis. D. Cattran, C.Greenwood, K. Bernstein, L. Hebert, M. Pohl, D. Maxwell, G. Appel, W. Hoy, M. Faber and R. Hegeman.- Toronto, Canada.

Program number 1547 at na
* Follow up results from a randomized controlled trial of cyclosporine versus placebo in adults with steroid resistant idiopathic focal segmental glomerulosclerosis. D. Cattran, C. Greenwood, L. Hebert, M. Pohl, l. Hunsicker, D. Maxwell and C. Kunis.- Toronto, Canada.

Program number 1550 at na
* Novel association between HLA DQ A1*05 and membranous glomerulonephritis. R.Perrichot, B. Mercier, B. Wehbe, J.P. Lenormand, O. Raguenes, C. Ferec and J. Cledes. - Brest, France.

Program number 1568 at na
* Membranoproliferative glomerulonephritis in childhood: Are steroids beneficial? B.Z. Morgenstern, J.M. Gloor, M.E. Murphy and D.S. Milliner. - Rochester, MN.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Clinical transplantation I

Program number 1806 Board# T356 at 10:00 A.M.
* Clinical picture and outcome of allograft membranous glomerulonephritis in renal transplant patients with hepatitis C virus infection. J.M. Morales, G. Fernandez-Zatarain, M.A. Munoz, G. Usera, M.A. Martinez, A. Fuertes, A. Andres and J.L. Rodicio. - Madrid, Spain.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Bone disease

Program number 1972 Board# T522 at 10:00 A.M.
* Increased bone metabolism in chronic glomerulonephritis patients with mild decline in creatinine clearance. T. Fujino, T. Suzuki, T. Sato, T. Yasuda, T. Maeba, T. Komoda, S. Owada and M. Ishida. - Kawasaki and Saitama, Japan.

4:00 P.M. ---Free communications--- San Diego Conv Ctr Rm 17a
Clinical transplantation II

Program number at 5:15
* Invited lecture: Treatment of recurrent focal sclerosing glomerulonephritis in renal allograft recipients. Virginia Savin. - Milwaukee, Wisconsin.

Wed. Nov. 8 1995

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 3
Infection and glomerular disease

Program number 2204 at 10:45
* Prevalence of hepatitis C antibodies in patients with glomerulopathies of native and transplant kidneys. A. Agarwal, F.G. Cosio, Z. Roche, M.E. Falkenhain and R.M.Ferguson. - Columbus, OH.

Program number 2205 at 11:00
* Streptococcal pyrogenic exotoxin B in acute post-streptococcal glomerulonephritis. G.A. Cu and J.B. Zabriskie. - New York, NY.

Program number 2208 at 11:45
* Glomerular disease in HIV infected patients with hepatitis C virus co-infection. M.B. Stokes, H. Chawla, R. Gertner, R.I. Brody, D. Goldfarb and G. Gallo. - New York, NY.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.